Indications and uses
treats head, pubic (crab), and body lice
treats head, pubic (crab), and body lice
Shake well before using Important: Read warnings before use adults and children 2 years and over: Inspect check each household member with a magnifying glass in bright light for lice/nits (eggs) look for tiny nits near scalp, beginning at back of neck and behind ears examine small sections of hair at at time unlike dandruff which moves when touched, nits stick to the hair if either lice or nits are fo...
store in cool and dry place keep carton for important product information see package insert for additional information.
Drug Facts
Piperonyl butoxide 4%
Pyrethrum extract (equivalent to 0.33% pyrethrins)
Lice Treatment
treats head, pubic (crab), and body lice
For external use only
allergic to ragweed. May cause breathing difficulty or an asthmatic attack.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Shake well before using
Important: Read warnings before usevegetables oil
DAILY CHECKING
To Prevent Reinfestation:
NDC No.: 76441-902-97
Comb with Magnifier Included
India's leading Lice Killer
Sujanil
Maximum Strength
Licel
Lice Treatment Oil
Proven and tested in India
for more than 4 Decades now in USA
Manufactured By:
Sujanil Chemo Industries
P.O. Box No. 1451, Marketyard P.O.,
Pune - 411037 (M.S.) India
Carton Label



| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 76441-902-97 | 2019-11-13 | C162847 | 48780-1 | 97449f38-badd-f6ea-e053-dbdaa90aa703 | Licel Lice Treatment Oil |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76441-902-97 | Licel | 1 in 1 BOX | OIL | 1 | 2 | |
| 76441-902-97 | Licel | 118 mL in 1 BOTTLE | OIL | 118 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| PIPERONYL BUTOXIDE | ACTIVE INGREDIENT | LWK91TU9AH | 2 | |
| PYRETHRUM EXTRACT | ACTIVE INGREDIENT | ZUM06L90GV | 2 | |
| PIPERONYL BUTOXIDE | ACTIVE MOIETY | LWK91TU9AH | 2 | |
| PYRETHRUM EXTRACT | ACTIVE MOIETY | ZUM06L90GV | 2 | |
| COCONUT OIL | INACTIVE INGREDIENT | Q9L0O73W7L | 2 | |
| SESAME OIL | INACTIVE INGREDIENT | QX10HYY4QV | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 76441-902 | 76441-902-97 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PIPERONYL BUTOXIDE | LWK91TU9AH | ACTIB |
| PYRETHRUM EXTRACT | ZUM06L90GV | ACTIB |
| SESAME OIL | QX10HYY4QV | IACT |
| COCONUT OIL | Q9L0O73W7L | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| COCONUT OIL | COCONUT OIL | Q9L0O73W7L | SOAP / TOPICAL | 4.6 %w/w | ||
| COCONUT OIL | COCONUT OIL | Q9L0O73W7L | AEROSOL, FOAM / TOPICAL | 23.6 %w/w | ||
| COCONUT OIL | COCONUT OIL | Q9L0O73W7L | TABLET / ORAL | NA | ||
| COCONUT OIL | COCONUT OIL | Q9L0O73W7L | CAPSULE, LIQUID FILLED / ORAL | NA | ||
| SESAME OIL | SESAME OIL | QX10HYY4QV | INJECTION / INTRAMUSCULAR | 70 %v/v | ||
| SESAME OIL | SESAME OIL | QX10HYY4QV | CAPSULE / ORAL | 2325 mg | ||
| COCONUT OIL | COCONUT OIL | Q9L0O73W7L | SOLUTION / TOPICAL | 15.5 %w/w | ||
| COCONUT OIL | COCONUT OIL | Q9L0O73W7L | OINTMENT / TOPICAL | 14.75 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 7cd2f3b6-3b50-4a00-99d5-86d7dd298efa | e165d005-2275-4f22-a6ac-fd5778e6f6c4 | 2012-09-14 | Warnings | 7cd2f3b6-3b50-4a00-99d5-86d7dd298efa e165d005-2275-4f22-a6ac-fd5778e6f6c4 |
Adverse event summaries are temporarily unavailable. Other product information remains available.